These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28724911

  • 1. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
    Balan M, Chakraborty S, Flynn E, Zurakowski D, Pal S.
    Sci Rep; 2017 Jul 19; 7(1):5900. PubMed ID: 28724911
    [Abstract] [Full Text] [Related]

  • 2. The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
    Banerjee P, Basu A, Arbiser JL, Pal S.
    Cancer Lett; 2013 Sep 28; 338(2):292-9. PubMed ID: 23752066
    [Abstract] [Full Text] [Related]

  • 3. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.
    Balan M, Mier y Teran E, Waaga-Gasser AM, Gasser M, Choueiri TK, Freeman G, Pal S.
    J Biol Chem; 2015 Mar 27; 290(13):8110-20. PubMed ID: 25645920
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.
    Datta D, Contreras AG, Basu A, Dormond O, Flynn E, Briscoe DM, Pal S.
    Cancer Res; 2009 Dec 01; 69(23):8902-9. PubMed ID: 19903851
    [Abstract] [Full Text] [Related]

  • 5. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW, Jung KH, Park BH, Zheng HM, Lee HS, Choi MJ, Yun JI, Kang NS, Lee J, Hong SS.
    Cancer Lett; 2013 May 10; 332(1):74-82. PubMed ID: 23348694
    [Abstract] [Full Text] [Related]

  • 6. Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.
    Basu A, Banerjee P, Contreras AG, Flynn E, Pal S.
    PLoS One; 2011 May 10; 6(8):e23919. PubMed ID: 21886838
    [Abstract] [Full Text] [Related]

  • 7. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB, Nagalingam A, Kuppusamy P, Bonner MY, Arbiser JL, Saxena NK, Sharma D.
    Oncotarget; 2015 Jun 30; 6(18):16396-410. PubMed ID: 26036628
    [Abstract] [Full Text] [Related]

  • 8. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC, Lee CF, Huang WH, Chou TC.
    Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 10. A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation.
    Sabarwal A, Wedel J, Liu K, Zurakowski D, Chakraborty S, Flynn E, Briscoe DM, Balan M, Pal S.
    Carcinogenesis; 2022 May 19; 43(4):360-370. PubMed ID: 34965300
    [Abstract] [Full Text] [Related]

  • 11. A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.
    Rawat L, Balan M, Sasamoto Y, Sabarwal A, Pal S.
    Redox Biol; 2023 Dec 19; 68():102945. PubMed ID: 37898101
    [Abstract] [Full Text] [Related]

  • 12. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
    Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP.
    Carcinogenesis; 2016 Nov 01; 37(11):1052-1061. PubMed ID: 27609457
    [Abstract] [Full Text] [Related]

  • 13. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal.
    Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, Pal S.
    J Biol Chem; 2011 Sep 23; 286(38):33580-90. PubMed ID: 21808062
    [Abstract] [Full Text] [Related]

  • 14. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
    Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir SJ, Umar S, Jensen RA, Anant S.
    Cells; 2021 Jun 26; 10(7):. PubMed ID: 34206989
    [Abstract] [Full Text] [Related]

  • 15. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J, Zou Y, Jiang D.
    Int J Mol Med; 2018 Apr 26; 41(4):1845-1854. PubMed ID: 29393336
    [Abstract] [Full Text] [Related]

  • 16. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
    Hahm ER, Singh KB, Singh SV.
    Cell Cycle; 2016 Sep 26; 15(17):2309-20. PubMed ID: 27341160
    [Abstract] [Full Text] [Related]

  • 17. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 18. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
    Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC.
    Blood; 2005 Sep 01; 106(5):1794-800. PubMed ID: 15870175
    [Abstract] [Full Text] [Related]

  • 19. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
    Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M.
    Cancer Prev Res (Phila); 2017 Feb 01; 10(2):133-141. PubMed ID: 27849557
    [Abstract] [Full Text] [Related]

  • 20. Honokiol inhibits HepG2 migration via down-regulation of IQGAP1 expression discovered by a quantitative pharmaceutical proteomic analysis.
    Liang S, Fu A, Zhang Q, Tang M, Zhou J, Wei Y, Chen L.
    Proteomics; 2010 Apr 01; 10(7):1474-83. PubMed ID: 20127691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.